Literature DB >> 16087183

Formulation and investigation of 5-FU nanoparticles with factorial design-based studies.

Asuman Bozkir1, Ongun Mehmet Saka.   

Abstract

This study describes an orthogonal experimental design to optimize the formulation of 5-fluorouracil (5-FU) loaded poly D,L (lactide-co-glycolide) (PLGA) nanoparticles (5FU-NP) by a nanoprecipitation-solvent displacement technique. The type of surfactant, amount of acetone and molecular weight of the polymer with three levels of each factor were selected and arranged in an L18(3(5)) orthogonal experimental table. From the statistical analysis of the data polynominal equations were generated. Optimized formulations have the particle size ranging from 160 to 250 nm. Smallest nanoparticles (161+/-1.22 nm) were obtained using Resomer PLGA 755 and pluronic F-68 with 10 ml acetone amount. Under these conditions the 5-FU entrapment percentage was maximum 78.30%, suggesting 5-FU might be entrapped and adsorbed on the nanoparticle surface. In vitro release of three formulations with maximum drug entrapment efficiency and minimum particle size, were also investigated by release kinetics. According to the determined coefficients, release data fit to Higuchi's diffusion kinetics. The in vitro release of 5FU-NP in phosphate buffered saline (PBS, pH 7.4) is suggested to be controlled by a combination of diffusion with slow and gradual erosion of the particles. Also, the antimicrobial activity was observed even on the end of seventh day with all formulations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16087183     DOI: 10.1016/j.farmac.2005.06.016

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  10 in total

1.  Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design.

Authors:  Mayank Shah; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2010-03-23       Impact factor: 3.246

2.  A Design of Experiment Study of Nanoprecipitation and Nano Spray Drying as Processes to Prepare PLGA Nano- and Microparticles with Defined Sizes and Size Distributions.

Authors:  Christina Draheim; Francois de Crécy; Steffi Hansen; Eva-Maria Collnot; Claus-Michael Lehr
Journal:  Pharm Res       Date:  2015-02-13       Impact factor: 4.200

3.  5-Fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release study.

Authors:  Amir Maghsoudi; Seyed Abbas Shojaosadati; Ebrahim Vasheghani Farahani
Journal:  AAPS PharmSciTech       Date:  2008-10-11       Impact factor: 3.246

4.  Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design.

Authors:  Jifu Hao; Xinsheng Fang; Yanfang Zhou; Jianzhu Wang; Fengguang Guo; Fei Li; Xinsheng Peng
Journal:  Int J Nanomedicine       Date:  2011-04-06

5.  A New Method for the Determination of Sucrose Concentration in a Pure and Impure System: Spectrophotometric Method.

Authors:  A Borji; Fz Borji; A Jourani
Journal:  Int J Anal Chem       Date:  2017-12-28       Impact factor: 1.885

6.  Developing micro-/nanoparticulate drug delivery systems using "design of experiments".

Authors:  Bhupinder Singh; Rahul Bhatowa; Chandra Bhushan Tripathi; Rishi Kapil
Journal:  Int J Pharm Investig       Date:  2011-04

Review 7.  Particles from preformed polymers as carriers for drug delivery.

Authors:  K Miladi; D Ibraheem; M Iqbal; S Sfar; H Fessi; A Elaissari
Journal:  EXCLI J       Date:  2014-02-03       Impact factor: 4.068

8.  Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles.

Authors:  Lalit Kumar; M Sreenivasa Reddy; Renuka S Managuli; Girish Pai K
Journal:  Saudi Pharm J       Date:  2015-03-03       Impact factor: 4.330

Review 9.  Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems.

Authors:  José L Arias
Journal:  Molecules       Date:  2008-10-01       Impact factor: 4.411

10.  Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets.

Authors:  Sileshi Belew; Sultan Suleman; Markos Duguma; Henok Teshome; Evelien Wynendaele; Luc Duchateau; Bart De Spiegeleer
Journal:  Malar J       Date:  2020-04-07       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.